Explorez tous les épisodes du podcast Apsida Insights
| Titre | Date | Durée | |
|---|---|---|---|
| London Calling | The Future of Apsida Life Science | 17 Jan 2025 | 00:33:27 | |
Senior Director Harry Williams joins Chief Commercial Officer Michael Georgiadis to discuss the bold launch of Apsida’s London office. They explore the vision behind the expansion, what makes London the perfect next step for Apsida, and how this new chapter sets the stage for exciting growth in 2025 and beyond. Harry shares his passion for building a culture of trust, innovation, and elite performance while offering insight into what it takes to create a thriving recruitment hub. Whether you’re curious about Apsida’s journey or considering joining the London team, this episode is a must-listen! | |||
| The Sofa | From 'The Boom' to Breakthrough | 19 Dec 2024 | 00:32:11 | |
Co-founders Ben, Jamie, and Michael reflect on the pivotal moments that shaped 2024—and how these experiences are setting the stage for an even bigger 2025. Join us for our first ‘Sofa Session’ as they discuss: • Lessons learned from the Covid boom and beyond. • The importance of culture, celebrating wins, and adapting to change. • How the London and Boston expansions are just the start of what’s to come. And this is only the beginning—future episodes take a closer, more personal look at Apsida’s journey. This series offers a deeper insight into the people, the passion, and the plans shaping Apsida’s future. | |||
| Diversifying Leadership | Dawn Brockett, CNS Summit | 11 Apr 2024 | 00:30:32 | |
Our host for this series is William Penticost, who is Head of Vendor Services at Apsida Life Science. We're kicking off 2024 with Dawn Brockett who is an author, keynote speaker, professor, advisor in the research and treatment of anorexia, and the managing director of CNS Summit. We would love to hear your feedback on our first episode and if you have any questions/ topics you would like us to discuss in future episodes then comment below. To read our key takeaways from the episode, follow the link below: https://apsida.co.uk/leadership/diversifying-leadership-dawn-brockett/ | |||
| Targeted Talks: Leaders in Oncology - Behzad Kharabi | 24 Sep 2024 | 00:41:45 | |
In our latest episode, Jamie Salmon sits down with the brilliant Behzad Kharabi, a leader who's transformed the oncology space. From an aspiring doctor to becoming a Chief Medical Officer with a global impact, Behzad's journey is nothing short of inspiring. In this episode, he shares the career-defining feedback that steered him from academia into industry, how he's navigated the challenges of leadership, and his powerful advice for the next generation of CMOs. Read our Key Takeaways from the episode here. | |||
| Targeted Talks: Leaders in Oncology - Eliel Bayever | 05 Sep 2024 | 00:31:07 | |
Welcome to the third instalment of Targeted Talks, in which our Co-Founder and Director, Jamie Salmon, sits down with world-class oncology leaders to hear about their journeys so far. In this edition, Eliel Bayever shares his story of being a well-respected paediatric clinician and diving head-first into the pharmaceutical industry much later than many of his peers. In our latest blog post, we’ll highlight some of the key takeaways from Jamie’s conversation with Eliel. | |||
| Targeted Talks: Leaders in Oncology | Elisabeth Oelmann | 05 Aug 2024 | 00:36:20 | |
Targeted Talks | Apsida’s Co-Founder and Director, Jamie Salmon, sits down with world-class oncology leaders to hear about their journeys so far. In this month's episode, Elisabeth Oelmann shares her inspiring story from being a ‘naive’ teenager in Germany to becoming an SVP oncology leader in the United Kingdom. During the conversation, Elisabeth highlights the secret to successfully managing a global remote team, what it’s really like to move from big pharma to small biotech, and more! Read our key takeaways from the episode. | |||
| Bonus Episode | Should Biotechs allow physicians to continue clinical practice? | 01 Aug 2024 | 00:07:19 | |
Apsida's Co-Founder Jamie Salmon, and Dr. Michael Grant (Executive Medical Director at Infinitropes) explore the mutual benefits of industry-based physicians maintaining a clinical practice. In our latest blog post, we also offer advice for biotechs keen to support physicians in this dual role and industry-based physicians aiming to continue their clinical practice. | |||
| Targeted Talks: Leaders in Oncology - Dr. Michael Grant | 05 Jul 2024 | 00:55:48 | |
Welcome to the first instalment of Targeted Talks, Apsida’s newest podcast and blog series in which our Co-Founder and Director, Jamie Salmon, sits down with world-class oncology leaders to hear about their journeys so far. In this edition, Dr Michael Grant shares his impressive story of following a traditional academic career before unexpectedly transitioning to the biotech industry. View our key takeaways from the episode here, where we provide relevant links from the episode. Faculty of Pharmaceutical Medicine guide | |||
| Introducing Target Talks: Leaders in Oncology | 20 Jun 2024 | 00:01:52 | |
With 10 years of experience and connections in the Oncology Clinical Development field, Jamie Salmon brings you inspiring stories and invaluable insights from industry leaders, in our latest Apsida Insights segment. Discover the unique career paths that led these pioneers to oncology, the passions that drive them, and their visions for the future. Get a glimpse into the human side of leadership, from team-building strategies to personal advice for aspiring professionals. Tune in to be inspired, informed, and empowered to make your impact in the world of Oncology. | |||
| Diversifying Leadership | Sarah McKeown-Cannon, Publicis Health | 29 Apr 2024 | 00:31:37 | |
Our next guest is Sarah McKeown-Cannon, who is the VP of Growth for Publicis Health and an expert in Clinical Trial Experience. As a rare disease patient herself, Sarah’s passion for human-centred research is personal. She challenges clients to think beyond the boundaries of “traditional” clinical trial design to solve their number one challenge - patient recruitment - by recognising patients as individuals and building truly inclusive clinical trials. Her leadership journey is inspiring, and we’re sure you’ll enjoy this episode just as much as we did. Read our key takeaways from this episode: https://apsida.co.uk/leadership/diversifying-leadership-sarah-mckeown-cannon/ | |||
| Diversifying Leadership | Jane Myles, DTRA | 11 Apr 2024 | 00:34:35 | |
Our second guest is Jane Myles, who is the Program Director for the DTRA and advisor to several life sciences organizations. Her career, spanning over two and a half decades, has seen her work for some of the most well-known and respected organisations in the world. We would love to hear your feedback on the series and if you have any questions/ topics you would like us to discuss in future episodes then comment below. To read our key takeaways from the episode, follow the link here: https://apsida.co.uk/leadership/diversifying-leadership-jane-myles/ | |||